Intraocular pressure-lowering effects and safety of brimonidine/brinzolamide fixed combination after switching from other medications

被引：0

作者：

Kenji Inoue

Shiho Kunimatsu-Sanuki

Kyoko Ishida

Goji Tomita

机构：

[1] Inouye Eye Hospital,Department of Ophthalmology

[2] Nishikasai Inouye Eye Hospital,undefined

[3] Toho University Ohashi Medical Center,undefined

来源：

Japanese Journal of Ophthalmology | 2022年 / 66卷

关键词：

Brimonidine/brinzolamide fixed combination; Intraocular pressure; Safety; Switching;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：440 / 446

页数：6

共 50 条

[41] Fixed Combination Brimonidine-Timolol Versus Brimonidine for Treatment of Intraocular Pressure Elevation After Neodymium: YAG Laser Posterior Capsulotomy
Oner, Veysi
Alakus, Mehmet Fuat
Tas, Mehmet
Turkyilmaz, Kemal
Iscan, Yalcin
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (06) : 576 - 580
[42] Comparison of the change in intraocular pressure with a fixed-dose combination of brinzolamide 1% and brimonidine 0.2% vs brinzolamide or brimonidine alone in patients with open-angle glaucoma or ocular hypertension: A post hoc, pooled, phase 3 analysis
Meng, Xiangyi
Sall, Kenneth N.
Wirta, David
Burmaster, Steve
Cai, Qing
Bacharach, Jason
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[43] Efficacy and safety of fixed-dose combination brinzolamide 1%/brimonidine 0.2% as adjunctive therapy to prostaglandin analogs in patients with elevated intraocular pressure: Results from pooled analysis of two multicenter, randomized studies
Hubatsch, Doug
Realini, Tony
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[44] Additive intraocular pressure-lowering effect of dorzolamide 1%/ timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
Mizoguchi, Takanori
Ozaki, Mineo
Wakiyama, Harumi
Ogino, Nobuchika
CLINICAL OPHTHALMOLOGY, 2011, 5 : 1515 - 1520
[45] A Comparative Study on Efficacy of Intraocular Pressure Lowering of Two Fixed-Dose Antiglaucoma Drug Combination Brinzolamide-Brimonidine Versus Latanoprost-Timolol in Primary Open-Angle Glaucoma and Ocular Hypertension
Mishra, Avinash
Agrawal, Mohini
Tripathi, Anchal
Bhirud, Atul
Kumar, Lt Col Rajnish
Vinod, Brig Baranwal K.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 40 (04) : 240 - 245
[46] Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers
Tanihara, Hidenobu
Inatani, Masaru
Honjo, Megumi
Tokushige, Hideki
Azuma, Junichi
Araie, Makoto
ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (03) : 309 - 315
[47] A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma
Martinez, Antonio
Sanchez, Manuel
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1025 - 1032
[48] Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies
Konstas, AGP
Banyái, L
Blask, KD
Väth, J
Kozobolis, VP
Trüb, PR
Tsironi, S
Maloutas, S
Teus, MA
Stewart, WC
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, 20 (05) : 375 - 382
[49] Effect of Brimonidine/Timolol Fixed Combination on Preventing the Short-Term Intraocular Pressure Increase after Intravitreal Injection of Ranibizumab
Theoulakis, P. E.
Lepidas, J.
Petropoulos, I. K.
Livieratou, A.
Brinkmann, C. K.
Katsimpris, J. M.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2010, 227 (04) : 280 - 284
[50] Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension: A randomized observer-masked multicenter study
Kampik, A
Arias-Puente, A
O'Brart, DPS
Vuori, ML
JOURNAL OF GLAUCOMA, 2002, 11 (02) : 90 - 96

← 1 2 3 4 5 →